Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Up – Still a Buy?

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) gapped up before the market opened on Friday . The stock had previously closed at $18.20, but opened at $18.90. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $18.89, with a volume of 5,270 shares changing hands.

Analyst Upgrades and Downgrades

TLX has been the topic of a number of research reports. William Blair raised Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research note on Tuesday, November 19th. UBS Group upped their price target on shares of Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the company a “buy” rating in a report on Monday, January 27th.

Telix Pharmaceuticals Limited American Depositary Shares Price Performance

The firm’s fifty day simple moving average is $16.16.

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.